Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c785 |
|---|---|
| Identifier | NCT05369832 |
| Trial Title | An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Ozanimod |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2022-12-16 |
|---|---|
| Primary Completion Date | 2025-01-21 |
| Completion Date | 2025-04-15 |